ECSP034700A - Nuevos derivados de m-alquil-fenilimino-imidazolidana para tratar la incontinencia urinaria - Google Patents

Nuevos derivados de m-alquil-fenilimino-imidazolidana para tratar la incontinencia urinaria

Info

Publication number
ECSP034700A
ECSP034700A EC2003004700A ECSP034700A ECSP034700A EC SP034700 A ECSP034700 A EC SP034700A EC 2003004700 A EC2003004700 A EC 2003004700A EC SP034700 A ECSP034700 A EC SP034700A EC SP034700 A ECSP034700 A EC SP034700A
Authority
EC
Ecuador
Prior art keywords
urinary incontinence
imidazolidana
fenilimino
alquil
new derivatives
Prior art date
Application number
EC2003004700A
Other languages
English (en)
Inventor
Matthias Hoffmann
Franz Esser
Pascale Pouzet
Hisato Kitagawa
Ikunobu Muramatsu
Kenji Sakai
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034700A publication Critical patent/ECSP034700A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención comprende derivados de m-alquil-fenilimino-imidazolidina con un nuevo modelo de sustituyentes en el anillo de fenilo y su uso para la preparación de medicamentos, en particular para el tratamiento de la incontinencia urinaria.
EC2003004700A 2001-02-10 2003-07-22 Nuevos derivados de m-alquil-fenilimino-imidazolidana para tratar la incontinencia urinaria ECSP034700A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10106214A DE10106214A1 (de) 2001-02-10 2001-02-10 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz

Publications (1)

Publication Number Publication Date
ECSP034700A true ECSP034700A (es) 2003-08-29

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004700A ECSP034700A (es) 2001-02-10 2003-07-22 Nuevos derivados de m-alquil-fenilimino-imidazolidana para tratar la incontinencia urinaria

Country Status (21)

Country Link
EP (1) EP1362038A1 (es)
JP (1) JP2004517963A (es)
KR (1) KR20030076653A (es)
CN (1) CN1491216A (es)
AR (1) AR035226A1 (es)
BG (1) BG108036A (es)
BR (1) BR0206949A (es)
CA (1) CA2437809A1 (es)
CZ (1) CZ20032146A3 (es)
DE (1) DE10106214A1 (es)
EA (1) EA200300835A1 (es)
EC (1) ECSP034700A (es)
EE (1) EE200300379A (es)
HU (1) HUP0303004A3 (es)
IL (1) IL157297A0 (es)
MX (1) MXPA03007127A (es)
NO (1) NO20033368L (es)
PL (1) PL362149A1 (es)
SK (1) SK10132003A3 (es)
WO (1) WO2002064570A1 (es)
ZA (1) ZA200305609B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2523253C (en) * 2003-05-09 2010-06-22 F. Hoffmann-La Roche Ag Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2761061B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
MXPA03007127A (es) 2003-11-18
NO20033368D0 (no) 2003-07-28
WO2002064570A1 (de) 2002-08-22
SK10132003A3 (sk) 2004-02-03
KR20030076653A (ko) 2003-09-26
DE10106214A1 (de) 2002-08-14
JP2004517963A (ja) 2004-06-17
NO20033368L (no) 2003-07-28
HUP0303004A2 (hu) 2003-12-29
BR0206949A (pt) 2004-02-25
HUP0303004A3 (en) 2004-07-28
EA200300835A1 (ru) 2004-02-26
PL362149A1 (en) 2004-10-18
EP1362038A1 (de) 2003-11-19
EE200300379A (et) 2003-12-15
CA2437809A1 (en) 2002-08-22
IL157297A0 (en) 2004-02-19
CN1491216A (zh) 2004-04-21
BG108036A (bg) 2004-12-30
AR035226A1 (es) 2004-05-05
CZ20032146A3 (cs) 2003-12-17
ZA200305609B (en) 2004-04-29

Similar Documents

Publication Publication Date Title
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
ME01222B (me) Nova kombinovana upotreba jedinjenja sulfonamida u liječenju kancera
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
SG146442A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
MXPA03007140A (es) Derivados de carbolina.
ATE461217T1 (de) Glp-1-verbindungen
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
SG145701A1 (en) Piperazine derivatives and their use as therapeutic agents
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
DOP2002000433A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
DE60216233D1 (en) Carbolinderivate
MEP49508A (me) Piperazinil i diazapanil benzamidi i benzotioamidi
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
PE20010623A1 (es) Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
MY146794A (en) Use of an alpha-2-delta ligand for the treatment of luts
SG139747A1 (en) Inhibitors of the mutant form of kit
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
ATE344828T1 (de) Azofarbstoffe
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
ATE433459T1 (de) Desoxo-nonadepsipeptide
UY27157A1 (es) Nuevos derivados de alquil-fenilimino-imidazolidina para el tratamiento de la incontinencia urinaria
SE0202365D0 (sv) New formulation and use thereof